+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Edoxaban Testing"

2022-2026 Global Edoxaban Testing in 90 Countries - Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2022-2026 Global Edoxaban Testing in 90 Countries - Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • March 2022
  • Global
From
2020 Edoxaban Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Edoxaban Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Edoxaban Testing market is a subset of the Diagnostics industry, focusing on the development and commercialization of tests for the detection of edoxaban, a direct oral anticoagulant. Edoxaban Testing is used to assess the risk of thromboembolic events in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Tests are typically conducted in a laboratory setting, and results are used to inform treatment decisions. The Edoxaban Testing market is highly competitive, with a number of companies offering tests for the detection of edoxaban. These companies include Siemens Healthineers, Abbott, Roche Diagnostics, and Sysmex Corporation. Show Less Read more